The Rapid and Efficient SARS-CoV-2 Nucleocapsid Antigen Detection Kit (Colloidal Gold) enables judicious detection of the SARS-CoV-2 nucleocapsid antigen, pivotal in COVID-19 detection. With a test result turnaround of 12 minutes, this tool ensures swift isolation or remedial measures. The kit, an in vitro diagnostic medical device, doesn’t demand additional equipment or readers. Key components include:
This reliable and user-friendly kit offers significant contribution in the fight against COVID-19.
The Rapid and Efficient SARS-CoV-2 Nucleocapsid Antigen Detection Kit (Colloidal Gold) is an innovative diagnostic tool, designed to deliver quick and accurate results for COVID-19 testing. It is a complete kit that includes high-quality components and operates based on the acclaimed immunochromatographic assay technology.
This kit's standout capability is its high sensitivity to the SARS-CoV-2 nucleocapsid antigen, which enables the detection of ongoing SARS-CoV-2 infections with remarkable accuracy. It uses a simple nasal swab sample - ensuring minimal discomfort, and provides much-needed convenience in these challenging times. The testing procedure is manual and needs no specialized equipment or automation. Results can be easily seen with the naked eye within a short span of just 12 minutes.
This SARS-CoV-2 Nucleocapsid Antigen Detection Kit is a critical tool in the ongoing fight against COVID-19. The kit has been developed with the highest quality standards and allows even remote locations access to accurate, rapid COVID-19 testing. This efficient diagnostic tool is a testament to our commitment to enhancing public safety and health.